nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—migraine—Prednisone—chronic obstructive pulmonary disease	0.497	1	CpDpCtD
Rizatriptan—CYP1A2—chronic obstructive pulmonary disease	0.351	1	CbGaD
Rizatriptan—Zolmitriptan—CYP1A2—chronic obstructive pulmonary disease	0.000869	0.271	CrCbGaD
Rizatriptan—Melatonin—MPO—chronic obstructive pulmonary disease	0.00077	0.24	CrCbGaD
Rizatriptan—Almotriptan—CYP1A2—chronic obstructive pulmonary disease	0.000659	0.206	CrCbGaD
Rizatriptan—Melatonin—CYP1A1—chronic obstructive pulmonary disease	0.000462	0.144	CrCbGaD
Rizatriptan—Melatonin—CYP1A2—chronic obstructive pulmonary disease	0.000445	0.139	CrCbGaD
Rizatriptan—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00182	CcSEcCtD
Rizatriptan—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00182	CcSEcCtD
Rizatriptan—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00182	CcSEcCtD
Rizatriptan—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00181	CcSEcCtD
Rizatriptan—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00181	CcSEcCtD
Rizatriptan—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00181	CcSEcCtD
Rizatriptan—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00181	CcSEcCtD
Rizatriptan—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00181	CcSEcCtD
Rizatriptan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00181	CcSEcCtD
Rizatriptan—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00181	CcSEcCtD
Rizatriptan—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.0018	CcSEcCtD
Rizatriptan—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000206	0.0018	CcSEcCtD
Rizatriptan—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00178	CcSEcCtD
Rizatriptan—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00178	CcSEcCtD
Rizatriptan—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00178	CcSEcCtD
Rizatriptan—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00178	CcSEcCtD
Rizatriptan—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00178	CcSEcCtD
Rizatriptan—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00177	CcSEcCtD
Rizatriptan—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00177	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000202	0.00176	CcSEcCtD
Rizatriptan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00176	CcSEcCtD
Rizatriptan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00174	CcSEcCtD
Rizatriptan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00174	CcSEcCtD
Rizatriptan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00174	CcSEcCtD
Rizatriptan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00174	CcSEcCtD
Rizatriptan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00174	CcSEcCtD
Rizatriptan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00172	CcSEcCtD
Rizatriptan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00172	CcSEcCtD
Rizatriptan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00172	CcSEcCtD
Rizatriptan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.00171	CcSEcCtD
Rizatriptan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00171	CcSEcCtD
Rizatriptan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00171	CcSEcCtD
Rizatriptan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00171	CcSEcCtD
Rizatriptan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00171	CcSEcCtD
Rizatriptan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00171	CcSEcCtD
Rizatriptan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00171	CcSEcCtD
Rizatriptan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.0017	CcSEcCtD
Rizatriptan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000195	0.0017	CcSEcCtD
Rizatriptan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.0017	CcSEcCtD
Rizatriptan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00169	CcSEcCtD
Rizatriptan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.00169	CcSEcCtD
Rizatriptan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00168	CcSEcCtD
Rizatriptan—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00168	CcSEcCtD
Rizatriptan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00167	CcSEcCtD
Rizatriptan—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00167	CcSEcCtD
Rizatriptan—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00165	CcSEcCtD
Rizatriptan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00164	CcSEcCtD
Rizatriptan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00164	CcSEcCtD
Rizatriptan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00162	CcSEcCtD
Rizatriptan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00162	CcSEcCtD
Rizatriptan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00161	CcSEcCtD
Rizatriptan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00161	CcSEcCtD
Rizatriptan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000182	0.00159	CcSEcCtD
Rizatriptan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.00159	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00159	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00159	CcSEcCtD
Rizatriptan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00158	CcSEcCtD
Rizatriptan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00158	CcSEcCtD
Rizatriptan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00157	CcSEcCtD
Rizatriptan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00157	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000178	0.00155	CcSEcCtD
Rizatriptan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00155	CcSEcCtD
Rizatriptan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00155	CcSEcCtD
Rizatriptan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00155	CcSEcCtD
Rizatriptan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00155	CcSEcCtD
Rizatriptan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00154	CcSEcCtD
Rizatriptan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00153	CcSEcCtD
Rizatriptan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00153	CcSEcCtD
Rizatriptan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00153	CcSEcCtD
Rizatriptan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00153	CcSEcCtD
Rizatriptan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00152	CcSEcCtD
Rizatriptan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000173	0.00151	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000172	0.0015	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.0015	CcSEcCtD
Rizatriptan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.0015	CcSEcCtD
Rizatriptan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000172	0.0015	CcSEcCtD
Rizatriptan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.0015	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.0015	CcSEcCtD
Rizatriptan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00149	CcSEcCtD
Rizatriptan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00149	CcSEcCtD
Rizatriptan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00149	CcSEcCtD
Rizatriptan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00149	CcSEcCtD
Rizatriptan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00149	CcSEcCtD
Rizatriptan—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00148	CcSEcCtD
Rizatriptan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00148	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00147	CcSEcCtD
Rizatriptan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00147	CcSEcCtD
Rizatriptan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00147	CcSEcCtD
Rizatriptan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00146	CcSEcCtD
Rizatriptan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00146	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00146	CcSEcCtD
Rizatriptan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.00146	CcSEcCtD
Rizatriptan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.00145	CcSEcCtD
Rizatriptan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00145	CcSEcCtD
Rizatriptan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00144	CcSEcCtD
Rizatriptan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.00144	CcSEcCtD
Rizatriptan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00144	CcSEcCtD
Rizatriptan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00144	CcSEcCtD
Rizatriptan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00143	CcSEcCtD
Rizatriptan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00143	CcSEcCtD
Rizatriptan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00143	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00142	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00142	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00142	CcSEcCtD
Rizatriptan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00142	CcSEcCtD
Rizatriptan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00141	CcSEcCtD
Rizatriptan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00141	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00016	0.0014	CcSEcCtD
Rizatriptan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00139	CcSEcCtD
Rizatriptan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00138	CcSEcCtD
Rizatriptan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00138	CcSEcCtD
Rizatriptan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00138	CcSEcCtD
Rizatriptan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00138	CcSEcCtD
Rizatriptan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00138	CcSEcCtD
Rizatriptan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00138	CcSEcCtD
Rizatriptan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00137	CcSEcCtD
Rizatriptan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.00136	CcSEcCtD
Rizatriptan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.00136	CcSEcCtD
Rizatriptan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00136	CcSEcCtD
Rizatriptan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00136	CcSEcCtD
Rizatriptan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00136	CcSEcCtD
Rizatriptan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000155	0.00135	CcSEcCtD
Rizatriptan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00135	CcSEcCtD
Rizatriptan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00135	CcSEcCtD
Rizatriptan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00135	CcSEcCtD
Rizatriptan—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00135	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00134	CcSEcCtD
Rizatriptan—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00133	CcSEcCtD
Rizatriptan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00131	CcSEcCtD
Rizatriptan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.0013	CcSEcCtD
Rizatriptan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.0013	CcSEcCtD
Rizatriptan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00128	CcSEcCtD
Rizatriptan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00128	CcSEcCtD
Rizatriptan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00128	CcSEcCtD
Rizatriptan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00126	CcSEcCtD
Rizatriptan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00125	CcSEcCtD
Rizatriptan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00125	CcSEcCtD
Rizatriptan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00123	CcSEcCtD
Rizatriptan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00123	CcSEcCtD
Rizatriptan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00123	CcSEcCtD
Rizatriptan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00122	CcSEcCtD
Rizatriptan—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00121	CcSEcCtD
Rizatriptan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00121	CcSEcCtD
Rizatriptan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00121	CcSEcCtD
Rizatriptan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00119	CcSEcCtD
Rizatriptan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00119	CcSEcCtD
Rizatriptan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00119	CcSEcCtD
Rizatriptan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00118	CcSEcCtD
Rizatriptan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00117	CcSEcCtD
Rizatriptan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00116	CcSEcCtD
Rizatriptan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00116	CcSEcCtD
Rizatriptan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00115	CcSEcCtD
Rizatriptan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00115	CcSEcCtD
Rizatriptan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00113	CcSEcCtD
Rizatriptan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00113	CcSEcCtD
Rizatriptan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00111	CcSEcCtD
Rizatriptan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00111	CcSEcCtD
Rizatriptan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000126	0.0011	CcSEcCtD
Rizatriptan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.0011	CcSEcCtD
Rizatriptan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000126	0.0011	CcSEcCtD
Rizatriptan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.0011	CcSEcCtD
Rizatriptan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00109	CcSEcCtD
Rizatriptan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00109	CcSEcCtD
Rizatriptan—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00109	CcSEcCtD
Rizatriptan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00109	CcSEcCtD
Rizatriptan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00108	CcSEcCtD
Rizatriptan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00108	CcSEcCtD
Rizatriptan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00107	CcSEcCtD
Rizatriptan—Headache—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00107	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00106	CcSEcCtD
Rizatriptan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00106	CcSEcCtD
Rizatriptan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00105	CcSEcCtD
Rizatriptan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00105	CcSEcCtD
Rizatriptan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Rizatriptan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Rizatriptan—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Rizatriptan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.00104	CcSEcCtD
Rizatriptan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00103	CcSEcCtD
Rizatriptan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00103	CcSEcCtD
Rizatriptan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00103	CcSEcCtD
Rizatriptan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00102	CcSEcCtD
Rizatriptan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00101	CcSEcCtD
Rizatriptan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.001	CcSEcCtD
Rizatriptan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000998	CcSEcCtD
Rizatriptan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000982	CcSEcCtD
Rizatriptan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000977	CcSEcCtD
Rizatriptan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000972	CcSEcCtD
Rizatriptan—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00096	CcSEcCtD
Rizatriptan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000943	CcSEcCtD
Rizatriptan—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000943	CcSEcCtD
Rizatriptan—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000928	CcSEcCtD
Rizatriptan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000921	CcSEcCtD
Rizatriptan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000912	CcSEcCtD
Rizatriptan—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000895	CcSEcCtD
Rizatriptan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000875	CcSEcCtD
Rizatriptan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.000862	CcSEcCtD
Rizatriptan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.78e-05	0.000853	CcSEcCtD
Rizatriptan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.71e-05	0.000847	CcSEcCtD
Rizatriptan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.69e-05	0.000845	CcSEcCtD
Rizatriptan—Erythema—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.00084	CcSEcCtD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.43e-05	0.00279	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.43e-05	0.00279	CbGpPWpGaD
Rizatriptan—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.43e-05	0.00279	CbGpPWpGaD
Rizatriptan—MAOA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.39e-05	0.00278	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.29e-05	0.00275	CbGpPWpGaD
Rizatriptan—Pain—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.000807	CcSEcCtD
Rizatriptan—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.19e-05	0.00272	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.17e-05	0.00271	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	9.11e-05	0.00269	CbGpPWpGaD
Rizatriptan—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.000792	CcSEcCtD
Rizatriptan—HTR1F—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.07e-05	0.00268	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	8.99e-05	0.00266	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.94e-05	0.00264	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.92e-05	0.00264	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.92e-05	0.00264	CbGpPWpGaD
Rizatriptan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.91e-05	0.000777	CcSEcCtD
Rizatriptan—MAOA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.9e-05	0.00263	CbGpPWpGaD
Rizatriptan—Agitation—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000772	CcSEcCtD
Rizatriptan—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.82e-05	0.00261	CbGpPWpGaD
Rizatriptan—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.000767	CcSEcCtD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.76e-05	0.00259	CbGpPWpGaD
Rizatriptan—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.65e-05	0.000755	CcSEcCtD
Rizatriptan—Syncope—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000753	CcSEcCtD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.63e-05	0.00255	CbGpPWpGaD
Rizatriptan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.59e-05	0.000749	CcSEcCtD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.58e-05	0.00254	CbGpPWpGaD
Rizatriptan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000738	CcSEcCtD
Rizatriptan—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000728	CcSEcCtD
Rizatriptan—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.000725	CcSEcCtD
Rizatriptan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000715	CcSEcCtD
Rizatriptan—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000715	CcSEcCtD
Rizatriptan—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000713	CcSEcCtD
Rizatriptan—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.1e-05	0.000707	CcSEcCtD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.05e-05	0.00238	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.99e-05	0.00236	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.97e-05	0.000695	CcSEcCtD
Rizatriptan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000686	CcSEcCtD
Rizatriptan—Oedema—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000686	CcSEcCtD
Rizatriptan—Shock—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000674	CcSEcCtD
Rizatriptan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.000672	CcSEcCtD
Rizatriptan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000669	CcSEcCtD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.64e-05	0.00226	CbGpPWpGaD
Rizatriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.62e-05	0.00225	CbGpPWpGaD
Rizatriptan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.59e-05	0.000663	CcSEcCtD
Rizatriptan—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.52e-05	0.00222	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.5e-05	0.00222	CbGpPWpGaD
Rizatriptan—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.49e-05	0.000653	CcSEcCtD
Rizatriptan—HTR1D—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.46e-05	0.00221	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.35e-05	0.00217	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.31e-05	0.00216	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.31e-05	0.00216	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	7.16e-05	0.00212	CbGpPWpGaD
Rizatriptan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000625	CcSEcCtD
Rizatriptan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.15e-05	0.000624	CcSEcCtD
Rizatriptan—HTR1F—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.13e-05	0.00211	CbGpPWpGaD
Rizatriptan—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.00062	CcSEcCtD
Rizatriptan—HTR1F—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.07e-05	0.00209	CbGpPWpGaD
Rizatriptan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000616	CcSEcCtD
Rizatriptan—HTR1F—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.99e-05	0.00207	CbGpPWpGaD
Rizatriptan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000603	CcSEcCtD
Rizatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.85e-05	0.00202	CbGpPWpGaD
Rizatriptan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.83e-05	0.000596	CcSEcCtD
Rizatriptan—Rash—Prednisolone—chronic obstructive pulmonary disease	6.82e-05	0.000595	CcSEcCtD
Rizatriptan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.81e-05	0.000594	CcSEcCtD
Rizatriptan—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.79e-05	0.00201	CbGpPWpGaD
Rizatriptan—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000591	CcSEcCtD
Rizatriptan—Headache—Prednisolone—chronic obstructive pulmonary disease	6.77e-05	0.000591	CcSEcCtD
Rizatriptan—Constipation—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000586	CcSEcCtD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.71e-05	0.00198	CbGpPWpGaD
Rizatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.7e-05	0.00198	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.57e-05	0.00194	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.53e-05	0.00193	CbGpPWpGaD
Rizatriptan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000565	CcSEcCtD
Rizatriptan—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.44e-05	0.0019	CbGpPWpGaD
Rizatriptan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000561	CcSEcCtD
Rizatriptan—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.42e-05	0.00056	CcSEcCtD
Rizatriptan—HTR1D—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.39e-05	0.00189	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.25e-05	0.00185	CbGpPWpGaD
Rizatriptan—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.000545	CcSEcCtD
Rizatriptan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000542	CcSEcCtD
Rizatriptan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000542	CcSEcCtD
Rizatriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.18e-05	0.00183	CbGpPWpGaD
Rizatriptan—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.92e-05	0.00175	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.87e-05	0.00173	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.8e-05	0.00171	CbGpPWpGaD
Rizatriptan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000505	CcSEcCtD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.74e-05	0.0017	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.71e-05	0.00169	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.68e-05	0.00168	CbGpPWpGaD
Rizatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.67e-05	0.00168	CbGpPWpGaD
Rizatriptan—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000492	CcSEcCtD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.6e-05	0.00165	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.6e-05	0.00165	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.57e-05	0.00165	CbGpPWpGaD
Rizatriptan—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.56e-05	0.000485	CcSEcCtD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.55e-05	0.00164	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.44e-05	0.00161	CbGpPWpGaD
Rizatriptan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000469	CcSEcCtD
Rizatriptan—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.37e-05	0.00159	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.36e-05	0.00158	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.33e-05	0.00157	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.22e-05	0.00154	CbGpPWpGaD
Rizatriptan—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.2e-05	0.000453	CcSEcCtD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.15e-05	0.00152	CbGpPWpGaD
Rizatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.11e-05	0.00151	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.11e-05	0.00151	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.05e-05	0.00149	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.04e-05	0.00149	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	5e-05	0.00148	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5e-05	0.00148	CbGpPWpGaD
Rizatriptan—Vomiting—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000436	CcSEcCtD
Rizatriptan—Rash—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000432	CcSEcCtD
Rizatriptan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000432	CcSEcCtD
Rizatriptan—Headache—Prednisone—chronic obstructive pulmonary disease	4.92e-05	0.000429	CcSEcCtD
Rizatriptan—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.76e-05	0.00141	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.74e-05	0.0014	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.72e-05	0.0014	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.67e-05	0.00138	CbGpPWpGaD
Rizatriptan—Nausea—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.000407	CcSEcCtD
Rizatriptan—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	4.61e-05	0.00136	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.59e-05	0.00136	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.58e-05	0.00135	CbGpPWpGaD
Rizatriptan—HTR1D—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.56e-05	0.00135	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.53e-05	0.00134	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.52e-05	0.00134	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.51e-05	0.00133	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.51e-05	0.00133	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.47e-05	0.00132	CbGpPWpGaD
Rizatriptan—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.46e-05	0.00132	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.43e-05	0.00131	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.42e-05	0.00131	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.38e-05	0.00129	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.37e-05	0.00129	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.33e-05	0.00128	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.32e-05	0.00128	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.32e-05	0.00128	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.29e-05	0.00127	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.26e-05	0.00126	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.1e-05	0.00121	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.05e-05	0.0012	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.98e-05	0.00118	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.98e-05	0.00118	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.95e-05	0.00117	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.86e-05	0.00114	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.84e-05	0.00114	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.83e-05	0.00113	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.82e-05	0.00113	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.81e-05	0.00113	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.79e-05	0.00112	CbGpPWpGaD
Rizatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.79e-05	0.00112	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.77e-05	0.00111	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.72e-05	0.0011	CbGpPWpGaD
Rizatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.62e-05	0.00107	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.59e-05	0.00106	CbGpPWpGaD
Rizatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.55e-05	0.00105	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.49e-05	0.00103	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.46e-05	0.00102	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.43e-05	0.00101	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.42e-05	0.00101	CbGpPWpGaD
Rizatriptan—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.4e-05	0.00101	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.37e-05	0.000997	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.35e-05	0.000992	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.33e-05	0.000985	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.28e-05	0.000971	CbGpPWpGaD
Rizatriptan—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.28e-05	0.000971	CbGpPWpGaD
Rizatriptan—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.24e-05	0.000957	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.23e-05	0.000955	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.16e-05	0.000935	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.16e-05	0.000934	CbGpPWpGaD
Rizatriptan—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.12e-05	0.000922	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.94e-05	0.000868	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.93e-05	0.000867	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.89e-05	0.000853	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.87e-05	0.000849	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.83e-05	0.000835	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.76e-05	0.000817	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.76e-05	0.000816	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.71e-05	0.000801	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.7e-05	0.000799	CbGpPWpGaD
Rizatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.7e-05	0.000799	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.7e-05	0.000799	CbGpPWpGaD
Rizatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.65e-05	0.000784	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.64e-05	0.000781	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.62e-05	0.000775	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.57e-05	0.000759	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.56e-05	0.000756	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.52e-05	0.000746	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.52e-05	0.000745	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.49e-05	0.000737	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.47e-05	0.000731	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.44e-05	0.000721	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.42e-05	0.000716	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.41e-05	0.000712	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.000678	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000672	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.24e-05	0.000664	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.21e-05	0.000655	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.2e-05	0.000651	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.19e-05	0.000647	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.15e-05	0.000636	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.12e-05	0.000626	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.1e-05	0.000619	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.06e-05	0.000609	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.06e-05	0.000609	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.02e-05	0.000597	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.98e-05	0.000585	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.97e-05	0.000582	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.95e-05	0.000578	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.88e-05	0.000557	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.88e-05	0.000557	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.88e-05	0.000555	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.84e-05	0.000543	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.75e-05	0.000517	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.75e-05	0.000517	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.73e-05	0.000512	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.00051	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.71e-05	0.000506	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.7e-05	0.000503	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.7e-05	0.000502	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.62e-05	0.000479	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.61e-05	0.000475	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.58e-05	0.000468	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.56e-05	0.000461	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.55e-05	0.000458	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.54e-05	0.000457	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.53e-05	0.000452	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.00045	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.52e-05	0.000448	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.51e-05	0.000445	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.47e-05	0.000436	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.000419	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.41e-05	0.000416	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.4e-05	0.000414	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.00041	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.38e-05	0.000407	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.35e-05	0.0004	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.33e-05	0.000392	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.31e-05	0.000387	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.29e-05	0.000382	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000373	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.26e-05	0.000372	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000368	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.23e-05	0.000365	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.18e-05	0.00035	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000344	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.15e-05	0.000341	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.06e-05	0.000314	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.06e-05	0.000312	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.05e-05	0.00031	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.04e-05	0.000306	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.01e-05	0.0003	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.01e-05	0.000299	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	9.9e-06	0.000293	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.88e-06	0.000292	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.75e-06	0.000288	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.67e-06	0.000286	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.56e-06	0.000283	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.43e-06	0.000279	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.39e-06	0.000278	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.3e-06	0.000275	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.24e-06	0.000273	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.19e-06	0.000272	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.57e-06	0.000253	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.39e-06	0.000248	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.37e-06	0.000247	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.19e-06	0.000242	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.03e-06	0.000237	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.96e-06	0.000235	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.79e-06	0.00023	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.72e-06	0.000228	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.57e-06	0.000224	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.41e-06	0.000219	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.37e-06	0.000218	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.35e-06	0.000217	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.04e-06	0.000208	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.8e-06	0.000201	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.65e-06	0.000197	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.45e-06	0.000191	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.36e-06	0.000188	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.24e-06	0.000185	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.24e-06	0.000184	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.12e-06	0.000181	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.11e-06	0.000181	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.99e-06	0.000177	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.93e-06	0.000175	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.92e-06	0.000175	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.64e-06	0.000167	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.61e-06	0.000166	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.13e-06	0.000152	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.07e-06	0.00015	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.03e-06	0.000149	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.7e-06	0.000139	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.65e-06	0.000138	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.6e-06	0.000136	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.56e-06	0.000135	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.83e-06	0.000113	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.82e-06	0.000113	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.65e-06	0.000108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.51e-06	0.000104	CbGpPWpGaD
